Lipiodol-TACE with idarubicin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Lipiodol-TACE with idarubicin, covering 2022-12-29 to 2022-12-29. Get the full timeline:
Most recent: Clinical Trial Update: Lipiodol-TACE With Idarubicin for Hepatocellular Carcinoma [Phase 2, Phase 3]